We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Hepatitis E virus (HEV) usually produces mild disease but in rare cases it can prove fatal, particularly in pregnant women.
Projects granted during 2015 that have a primary purpose of translational and applied research: human immune disorders.
Projects granted during 2016 that have a primary purpose of basic research, immune system.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Information for healthcare professionals on the diagnosis, prevention and treatment of hepatitis B.
How to spot chronic wasting disease (CWD), what to do if you suspect it and measures to prevent its spread.
Projects granted during 2014 that have a primary purpose of basic research: oncology.
Projects granted during 2015 that have a primary purpose of basic research: immune system.
The characteristics, diagnosis, management, surveillance and epidemiology of Clostridioides difficile (C. difficile).
Paper prepared by the Royal Society for the Scientific Advisory Group for Emergencies (SAGE).
Projects granted during 2014 that have a primary purpose of translational and applied research: other human disorders.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (11 March 2024) approved the medicine etrasimod (Velsipity) to treat people with moderately to severely active ulcerative colitis.
Projects granted during 2015 that have a primary purpose of basic research: oncology.
Patients with severe alopecia areata (patchy hair loss) could access a new medicine to help treat their condition.
Find out about the long-term effects some people can have after having COVID-19.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.